Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Jun 10;8(6):55. doi: 10.3390/cancers8060055

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 by the authors; licensee MDPI, Basel, Switzerland.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

MOAP-1 expression and its correlation with RASSF1A expression in different cancers. (a) MOAP-1 expression in different cancers (red) compared to normal (blue). TPB, TATA-binding protein. (b) Scatterplot of the expression values (normalized to GAPDH) of RASSF1A and MOAP-1 for thyroid (n = 55), breast (n = 77) and colorectal cancer (n = 31) patients. (c) Scatterplot of the expression values (log2[RSEM+1]) of RASSF1A (horizontal) and MOAP-1 (vertical) for primary tumors from TCGA breast cancer (n = 1062), colorectal adenocarcinoma (n = 286), lung adenocarcinoma (n = 488) and pancreatic adenocarcinoma (n = 178), patient samples. In (b,c), lines indicate linear regression; Spearman’s correlation coefficients and associated p-values are displayed in the bottom right corners.

MOAP-1 expression and its correlation with RASSF1A expression in different cancers. (a) MOAP-1 expression in different cancers (red) compared to normal (blue). TPB, TATA-binding protein. (b) Scatterplot of the expression values (normalized to GAPDH) of RASSF1A and MOAP-1 for thyroid (n = 55), breast (n = 77) and colorectal cancer (n = 31) patients. (c) Scatterplot of the expression values (log2[RSEM+1]) of RASSF1A (horizontal) and MOAP-1 (vertical) for primary tumors from TCGA breast cancer (n = 1062), colorectal adenocarcinoma (n = 286), lung adenocarcinoma (n = 488) and pancreatic adenocarcinoma (n = 178), patient samples. In (b,c), lines indicate linear regression; Spearman’s correlation coefficients and associated p-values are displayed in the bottom right corners.